Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)

South Korea · Delayed Price · Currency is KRW

9,320.00

-200.00 (-2.10%)

May 14, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cancer Immunotherapy Drugs	1.90B	Log In
Cancer Immunotherapy Drugs Growth	13737.27%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
South Korea	1.90B	Log In
South Korea Growth	13737.27%	Log In